CA672478A - Psilocybin and psilocin - Google Patents

Psilocybin and psilocin

Info

Publication number
CA672478A
CA672478A CA672478A CA672478DA CA672478A CA 672478 A CA672478 A CA 672478A CA 672478 A CA672478 A CA 672478A CA 672478D A CA672478D A CA 672478DA CA 672478 A CA672478 A CA 672478A
Authority
CA
Canada
Prior art keywords
psilocin
psilocybin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA672478A
Inventor
Heim Roger
Hofmann Albert
Brack Arthur
Kobel Hans
Cailleux Roger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Publication date
Application granted granted Critical
Publication of CA672478A publication Critical patent/CA672478A/en
Expired legal-status Critical Current

Links

CA672478A Psilocybin and psilocin Expired CA672478A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA672478T

Publications (1)

Publication Number Publication Date
CA672478A true CA672478A (en) 1963-10-15

Family

ID=35972836

Family Applications (1)

Application Number Title Priority Date Filing Date
CA672478A Expired CA672478A (en) Psilocybin and psilocin

Country Status (1)

Country Link
CA (1) CA672478A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2576059A (en) * 2017-10-09 2020-02-05 Compass Pathways Ltd Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11564935B2 (en) 2019-04-17 2023-01-31 Compass Pathfinder Limited Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
US11724985B2 (en) 2020-05-19 2023-08-15 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11851451B2 (en) 2017-10-09 2023-12-26 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US10947257B2 (en) 2017-10-09 2021-03-16 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US10954259B1 (en) 2017-10-09 2021-03-23 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11149044B2 (en) 2017-10-09 2021-10-19 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11180517B2 (en) 2017-10-09 2021-11-23 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2576059B (en) * 2017-10-09 2022-06-29 Compass Pathfinder Ltd A pharmaceutical formulation comprising psilocybin
US11447510B2 (en) 2017-10-09 2022-09-20 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11505564B2 (en) 2017-10-09 2022-11-22 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2576059A (en) * 2017-10-09 2020-02-05 Compass Pathways Ltd Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11629159B2 (en) 2017-10-09 2023-04-18 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11939346B2 (en) 2017-10-09 2024-03-26 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11564935B2 (en) 2019-04-17 2023-01-31 Compass Pathfinder Limited Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
US11738035B2 (en) 2019-04-17 2023-08-29 Compass Pathfinder Limited Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
US11746088B2 (en) 2020-05-19 2023-09-05 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
US11834410B2 (en) 2020-05-19 2023-12-05 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
US11724985B2 (en) 2020-05-19 2023-08-15 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
US11958807B2 (en) 2020-05-19 2024-04-16 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use

Similar Documents

Publication Publication Date Title
CA672478A (en) Psilocybin and psilocin
CA655470A (en) Muffler
AU287361B2 (en) N-phenyloxyalkyl n-phenalkoxyamines and related compounds
CA672962A (en) Suspended files
CA664820A (en) Oxygenator
CA665228A (en) Acoustic devices
AU275537B2 (en) Acoustic character logging
CA673421A (en) Counterbalance
AU289492B2 (en) Muffler
AU289056B2 (en) Muffler
AU291145B2 (en) Muffler
AU288016B2 (en) Muffler
CA670443A (en) Anti-smog muffler
CA656682A (en) Muffler
AU295749B2 (en) Muffler
AU292145B2 (en) Muffler
CA657116A (en) Muffler
AU290765B2 (en) Muffler
AU275017B2 (en) Muffler
AU289482B2 (en) Muffler
AU279499B2 (en) Iodiphors
AU281585B2 (en) D-homo-steroids
AU270797B2 (en) Anthelmitic 5-arylazorhodanines
CA666709A (en) Disjoncteurs pneumatiques
AU269943B2 (en) 3-aminosteroids